World's Best Scientists 2026 revealed!
Neoplasia
H-index 28

Neoplasia

0212-9787

Published by: Elsevier

https://www.journals.elsevier.com/neoplasia

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 939 129 127 24

Additional Metrics

Number of Best Scientists*: 327
Documents by Best Scientists*: 257
Top 100 Ranked Scientists*: 12
SCIMAGO H-index:
SCIMAGO SJR:
Impact Factor: 7.7

Overview

Top Research Topics at Neoplasia?

The concepts of Cancer research, Molecular biology, Pathology, Cancer and Cell biology are tackled in Neoplasia. The concepts on Cancer research presented in Neoplasia can also apply to other research fields, including Cell culture, Cell growth, Carcinogenesis, Cancer cell and Signal transduction. Cell culture study tackled is connected to the field of Apoptosis.

The study on Cell growth presented in it intersects with the topics under Cell cycle. It explores issues in Molecular biology which can be linked to other research areas like Gene expression, DNA methylation, Transfection, Gene and Regulation of gene expression. Pathology research featured in the journal incorporates concerns from various other topics such as Magnetic resonance imaging, Angiogenesis, Metastasis and In vivo.

The work on Angiogenesis addressed in the journal expands to the thematically related Vascular endothelial growth factor A. Research on Cancer presented in it concerns the broader topic of Internal medicine.

  • Cancer research (54.08%)
  • Molecular biology (20.89%)
  • Pathology (17.10%)

What are the most cited papers published in the journal?

  • ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform (2472 citations)
  • UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. (1568 citations)
  • Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations (1515 citations)

Research areas of the most cited articles at Neoplasia:

The journal articles explore disciplines such as Cancer research, Molecular biology, Pathology, Cancer and Cell biology. Specifically, studies on Angiogenesis are prevalent in the Cancer research works discussed in the journal papers. Issues in Pathology were discussed in the journal papers, taking into consideration concepts from other disciplines like Magnetic resonance imaging, Metastasis, Tumor progression, In vivo and Adenocarcinoma.

What topics the last edition of the journal is best known for?

  • Gene
  • Cancer
  • Internal medicine

The previous edition focused in particular on these issues:

The journal focuses on Cancer research, Cancer, Metastasis, Carcinogenesis and Cancer cell. Cell culture, Gene, Gene knockdown, Cell growth and In vivo are some topics wherein Cancer research research discussed in Neoplasia have an impact. The journal discusses concepts in Adenocarcinoma and Tumor microenvironment under Cancer and how they intertwine with disciplines like Context (language use).

The research on Metastasis featured in the journal combines topics in other fields like Cell migration, Breast cancer, Triple-negative breast cancer, Melanoma and Colorectal cancer. Neoplasia addresses concerns in Carcinogenesis which are intertwined with other disciplines, such as Receptor, Gene silencing, Catenin and Cell biology. The work on Cancer cell tackled in it brings together disciplines like Protein kinase B, Head and neck squamous-cell carcinoma, Transmembrane protein, Mesenchymal stem cell and Immunotherapy.

The most cited articles from the last journal are:

  • Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment. (4 citations)
  • The forces driving cancer extracellular vesicle secretion. (4 citations)
  • Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Neoplasia (based on the number of publications) are:

  • Arul M. Chinnaiyan (36 papers) absent at the last edition,
  • Ralph Weissleder (24 papers) absent at the last edition,
  • Kenneth J. Pienta (23 papers) absent at the last edition,
  • Mark A. Rubin (22 papers) absent at the last edition,
  • Alnawaz Rehemtulla (21 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Neoplasia (based on the number of publications) are:

  • University of Michigan (180 papers) published 4 papers at the last edition, 4 less than at the previous edition,
  • University of Texas MD Anderson Cancer Center (107 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • Harvard University (83 papers) published 1 paper at the last edition the same number as at the previous edition,
  • National Institutes of Health (65 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • University of Toronto (41 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.02% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 11.34% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.15% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.43% of all publications and 69.07% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Implications and Applications Outside Academia

While much of the work done in the field of Neoplasia is academic and scientific in nature, its implications widely affect other fields as well. For example, nursing professionals, specifically those specializing as Licensed Practical Nurses (LPN) often need an understanding of neoplasia to manage their responsibilities effectively. Particularly in states with a high incidences of cancer, such as Mississippi, LPN's are often one of the first caregivers for individuals diagnosed with cancer. Understanding the latest research, treatments, and diagnosis can make a difference in patient outcomes. There are a number of lpn programs in Mississippi, for instance, that include classes in basics of neoplasia and its various aspects in their curriculum. For nurses already working, continuing education courses and updates in the field through licensed journals like Neoplasia can also provide invaluable information. An understanding of the various aspects of Neoplasia research and its evolving nature is a must-have for healthcare professionals involved in cancer care. This relationship between academia and workplace validates further the importance of keeping pace with the latest research and finding ways to translate this knowledge into practical applications which can truly make a difference in patient's lives.

Top Publications

  • UALCAN: An update to the integrated cancer data analysis platform

    (2022)
    1955 Citations
  • ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.

    Varun Vijay Prabhu;Sara Morrow;Abed Rahman Kawakibi;Lanlan Zhou

    (2020)
    123 Citations
  • Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment

    Steven Kregel;Chao Wang;Xin Han;Lanbo Xiao

    (2020)
    114 Citations
  • STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications.

    Isidora Tošić;Isidora Tošić;David A. Frank

    (2021)
    76 Citations
  • SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets.

    Sandra N. Freiberger;Muriel Brada;Christine Fritz;Sylvia Höller

    (2021)
    53 Citations
  • The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science

    (2023)
    48 Citations
  • Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer

    (2022)
    44 Citations
  • Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery.

    T.A. Arsiwala;S.A. Sprowls;K.E. Blethen;C.E. Adkins

    (2021)
    39 Citations
  • Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)

    (2022)
    39 Citations
  • Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics.

    Renee Brady-Nicholls;Jingsong Zhang;Tian Zhang;Andrew Z Wang

    (2021)
    33 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine but seeking diverse educational routes, several online degrees offer valuable career pathways. An online ASN program provides foundational nursing skills, allowing students to enter the healthcare field quickly with hands-on training balanced by flexible digital coursework.

Nutrition plays a crucial role in preventive medicine and patient care. Pursuing an online degree in nutrition equips students with knowledge on diet, wellness, and therapeutic nutrition that complements clinical practice or public health careers.

Leadership and administration skills are equally important in healthcare. Accredited programs like a CAHME-accredited online MHA programs prepare graduates for healthcare management roles focused on improving systems and patient outcomes.

Advanced clinical practice options are also evolving. Some students explore a DNP program without clinical hours, which offers flexibility for working professionals while emphasizing leadership, evidence-based practice, and healthcare innovation.

Exploring these online options helps future healthcare professionals tailor their education to personal goals while expanding opportunities beyond traditional medical school tracks.

Best Scientists Contributing to This Journal

Recently Published Articles